The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Boehringer Ingelheim International GmbHEU/1/11/707/001-011

Main Information

Trade NameTrajenta
Active SubstancesLinagliptin
Dosage FormFilm-coated tablet
Licence HolderBoehringer Ingelheim International GmbH
Licence NumberEU/1/11/707/001-011

Group Information

ATC CodeA10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH05 linagliptin


License statusAuthorised
Licence Issued24/08/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back